The University of Chicago has received a $10 million gift from the Lohengrin Foundation to help establish a center of excellence in research on amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
ALS and its related conditions are devastating neurological diseases. Also known as Lou Gehrig’s disease, ALS progressively destroys nerve cells that control body movements, and affects as many as 30,000 Americans each year. There is no known cure to stop or reverse it, and only a handful of drugs approved by the FDA provide modest benefits for patients, so the search for new therapies continues.
The gift from the Lohengrin Foundation will establish the Center for Motor Neuron Disease (CMND) at UChicago to support biological research on the cellular processes and genetic causes of these conditions, as well as clinical studies into potential treatments. It will also fund annual lectures, conferences, postdoctoral fellowships and educational outreach programs at local Chicago secondary schools.
Click here to read the full story.
This story was first published by UChicago Medicine.
